Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation Pediatrics 2022;150 (3):e2022058859 [full text] [pubmed] Bilitool™ is designed to help clinicians assess the risks toward the development of hyperbilirubinemia or jaundice in newborns over 35 weeks gestational age. Bilirecs is a clinical decision support tool developed at stanford medicine children’s health It implements the 2022 american academy of pediatrics guideline for the management of hyperbilirubinemia in newborn infants at 35 or more weeks of gestation. We developed and implemented premie bilirecs (pbr), a novel cds tool for phototherapy initiation in preterm infants from 27 through 34 weeks postmenstrual age
The primary outcome measure was the proportion of phototherapy initiation events consistent with recommended tb thresholds.
OPEN
